Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. DaratumuMAb+>2
USA. J. DaratumuMAb+>2's subsections
(*) USA Approval Date: 2017. 06.
+Pomalidomide+Dexamethasone
>Prior Lines .. Including
Company
TradeMark
TradeMark Web-Site
USA. J. DaratumuMAb+>2's products
This section has no products